Gaps in Guideline-Based Lipid-Lowering Therapy for Secondary Prevention in the United States: A Retrospective Cohort Study of 322 153 Patients

• Published in: Circulation Cardiovascular quality and outcomes Vol. 16; no. 8; pp. 533 - 543
• Main Authors: Navar, Ann Marie, Kolkailah, Ahmed A, Gupta, Anand, Gillard, Kristin Khalaf, Israel, Marc K, Wang, Yiqing, Peterson, Eric D
• Format: Journal Article
• Language: English
• Published: United States 01.08.2023
• Subjects: Aged; Cardiovascular Diseases - prevention & control; Child, Preschool; Cholesterol, LDL; Ezetimibe - therapeutic use; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors - adverse effects; Male; Retrospective Studies; Secondary Prevention; United States - epidemiology; United States; underutilization; atherosclerotic cardiovascular disease; low-density lipoprotein cholesterol; statin therapy

Many patients with atherosclerotic cardiovascular disease (ASCVD) are not on guideline-recommended statin therapy. We evaluated utilization of statins and other lipid-lowering therapy (LLT), and changes in low-density lipoprotein cholesterol (LDL-C), among patients with ASCVD over a 1-year period. L...